Ramaprasannakumar Shwethashri Kondavagilu, Bhadrinarayan Varadarajan, Venkataramaiah Sudhir
Department of Neuroanaesthesia and Neurocritical Care, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India.
Anesth Essays Res. 2022 Jul-Sep;16(3):345-352. doi: 10.4103/aer.aer_45_22. Epub 2022 Dec 9.
Magnetic resonance imaging (MRI) under sedation requires faster recovery for early discharge and feeding resumption in children with neuropsychiatric disorders. The use of dexmedetomidine alone results in delayed recovery. Propofol, when used alone, can cause hypotension and respiratory depression. A new regimen for sedation was evaluated by exploiting the properties of these drugs, to allow faster recovery with minimal adverse events.
One hundred and fifty children aged 2-12 years requiring MRI were randomly allocated to these three groups. Group P ( = 50) received propofol bolus at 2 mg.kg over 10 min followed by infusion at 100 μg.kg.min. Group D ( = 50) received dexmedetomidine bolus of 2 μg.kg over 10 min followed by infusion at 1 μg.kg.h. Group PD ( = 50) received propofol bolus at 2 mg.kg over 10 min followed by dexmedetomidine infusion at 1 μg.kg.h. Recovery characteristics were noted.
Recovery following sedation in Group PD (15 ± 7.0 min) and Group P (17.35 ± 7.4 min) were comparable and significantly ( = 0.03) lesser than Group D (27.58 ± 8.09 min). Emergence delirium scores were significantly less in Group PD (5 ± 1.08) and Group D (5.6 ± 2.4), unlike scores in Group P (9 ± 2.43). About 79.5% (39/49) of children in Group P, 88.2% (45/51) of children in Group D, and 86% (43/50) of children in Group PD completed MRI without any movement. Seven (14.58%) in Group P, 2 (4%) in Group D, and 5 (10.20%) in Group PD required rescue sedation.
The regimen with propofol bolus and dexmedetomidine infusion provided adequate sedation and better recovery characteristics in children aged 2-12 years without systemic complications, as compared to the use of either agent alone.
对于患有神经精神疾病的儿童,镇静状态下的磁共振成像(MRI)检查需要更快恢复,以便早期出院并恢复进食。单独使用右美托咪定会导致恢复延迟。单独使用丙泊酚会引起低血压和呼吸抑制。通过利用这些药物的特性评估了一种新的镇静方案,以实现更快恢复且不良事件最少。
150名年龄在2至12岁需要进行MRI检查的儿童被随机分为三组。P组(n = 50)在10分钟内静脉推注丙泊酚2mg/kg,随后以100μg/kg·min的速度输注。D组(n = 50)在10分钟内静脉推注右美托咪定2μg/kg,随后以1μg/kg·h的速度输注。PD组(n = 50)在10分钟内静脉推注丙泊酚2mg/kg,随后以1μg/kg·h的速度输注右美托咪定。记录恢复特征。
PD组(15±7.0分钟)和P组(17.35±7.4分钟)镇静后的恢复情况相当,且显著(P = 0.03)短于D组(27.58±8.09分钟)。PD组(5±1.08)和D组(5.6±2.4)的苏醒期谵妄评分显著低于P组(9±2.43)。P组约79.5%(39/49)、D组88.2%(45/51)、PD组86%(43/50)的儿童在MRI检查过程中未出现任何移动。P组7名(14.58%)、D组2名(4%)、PD组5名(10.20%)儿童需要追加镇静。
与单独使用任何一种药物相比,丙泊酚推注联合右美托咪定输注的方案在2至12岁儿童中提供了充分的镇静效果和更好的恢复特征,且无全身并发症。